glp 1 blindness study A nurse lost her eyesight while on GLP-1 drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S The Effect of Semaglutide and

Specific research has quantified these differences

Since NAION cannot be reversed, it is crucial for anyone undergoing GLP-1 therapy to seek immediate medical attention if they notice any changes in their eyesight

As First-Line Treatment Guidelines increasingly support GLP-1 agonists as first-line treatment alongside or instead of metformin: When to consider first-line GLP-1: Established cardiovascular disease High cardiovascular risk Significant obesity (BMI 35+) Strong desire for weight loss Insurance coverage available Traditional metformin-first approach: Lower cost without insurance Decades of safety data Effective for many patients Can add GLP-1 later if needed For many patients, starting with a GLP-1 medication rather than metformin provides superior comprehensive benefit

That does not mean every breastfeeding mother should use injectable semaglutide

Originally developed for managing blood sugar, these treatments, including well-known options like semaglutide and tirzepatide, have a powerful effect on the hormones that regulate appetite and satiety

Demand has been driven by social media influencers and celebrities, leading many people to use the drugs off-label, meaning for a condition other than that for which it has been officially approved